Skip to main content
. 2019 Aug 22;8(13):6064–6081. doi: 10.1002/cam4.2494

Table 2.

Univariate and multivariate analyses for prognostic factors in NSCLC patients

Variables Univariate Multivariate
HR 95% Cl P HR 95% Cl P
Age, y (>65 vs ≤65) 0.97 0.45‐2.09 .93      
Gender (male vs female) 0.54 0.26‐1.15 .54      
Smoking (no vs yes) 0.59 0.28‐1.27 .18      
Histology (squamous vs nonsquamous) 2.22 1‐4.93 .05 2.49 1.12‐5.56 .026
T status (T3‐4 vs T1‐2) 1.34 0.64‐2.82 .44      
N status (N1‐3 vs N0) 1.65 0.78‐3.48 .19      
Stage Ⅲ vs Ⅰ‐Ⅱ 0.57 0.26‐1.27 .17      
Differentiation (poor vs well moderate) 1.51 0.68‐3.35 .31      
EGFR mutation status (mutated vs wild‐type) 2.27 1.04‐4.95 .04 2.53 1.15‐5.57 .02

Abbreviations: CI, confidence interval; EGFR, epidermal growth factor receptor; HR, hazard ratio; NSCLC, non‐small cell lung cancer.